Evaluating the efficacy of harmol in treating herpes simplex virus-induced keratitis Post author: Post published: May 29, 2024 Post category:uncategorized The antiviral efficacy and therapeutic potential of harmol in treating herpes simplex virus type 1 (HSV-1) induced keratitis You Might Also Like New insights into how the brain accesses information January 27, 2026 EACVI 2025 brings cardiac imaging experts together in Vienna November 26, 2025 BGI Genomics report uncovers knowledge gaps and barriers to thalassemia screening November 20, 2023